logo

CUE

Cue Biopharma·NASDAQ
--
--(--)
--
--(--)

CUE fundamentals

Cue Biopharma (CUE) released its earnings on Aug 12, 2025: revenue was 2.95M (YoY +11.14%), beat estimates; EPS was -0.09 (YoY +55.00%), beat estimates.
Revenue / YoY
2.95M
+11.14%
EPS / YoY
-0.09
+55.00%
Report date
Aug 12, 2025
Earnings Call
4:30 PM on Aug 18, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

CUE has released its 2025 Q4 earnings report, with revenue of 21.94M, reflecting a YoY change of 1292.26%, and net profit of 1.58M, showing a YoY change of 116.69%. The Sankey diagram below clearly presents CUE's revenue sources and cost distribution.

Key Indicators

Cue Biopharma (CUE) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Cue Biopharma (CUE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Cue Biopharma (CUE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Cue Biopharma (CUE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Cue Biopharma (CUE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Cue Biopharma (CUE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield